News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
291,832 Results
Type
Article (15139)
Company Profile (101)
Press Release (276592)
Section
Business (94787)
Career Advice (497)
Deals (16288)
Drug Delivery (73)
Drug Development (43712)
Employer Resources (57)
FDA (7318)
Job Trends (6756)
News (165641)
Policy (15485)
Tag
Academia (490)
Alliances (24063)
Alzheimer's disease (516)
Approvals (7348)
Artificial intelligence (104)
Bankruptcy (153)
Best Places to Work (4930)
Breast cancer (100)
Cancer (746)
Cardiovascular disease (64)
Career advice (431)
Cell therapy (126)
Clinical research (37144)
Collaboration (330)
Compensation (139)
COVID-19 (901)
C-suite (123)
Data (735)
Diabetes (94)
Diagnostics (1672)
Drug pricing (63)
Earnings (35671)
Events (41165)
Executive appointments (416)
FDA (7770)
Funding (244)
Gene therapy (118)
GLP-1 (358)
Government (1441)
Healthcare (4360)
Infectious disease (937)
Inflammatory bowel disease (59)
Interviews (62)
IPO (6541)
Job creations (2093)
Job search strategy (392)
Layoffs (208)
Legal (3518)
Lung cancer (101)
Lymphoma (69)
Manufacturing (142)
Medical device (2356)
Medtech (2358)
Mergers & acquisitions (9917)
Metabolic disorders (272)
Neuroscience (706)
NextGen: Class of 2025 (1718)
Non-profit (737)
Northern California (885)
Obesity (146)
Opinion (132)
Patents (95)
People (30997)
Pharmaceutical (64)
Phase I (9082)
Phase II (15325)
Phase III (15286)
Pipeline (424)
Postmarket research (1504)
Preclinical (3446)
Radiopharmaceuticals (129)
Rare diseases (186)
Real estate (2705)
Regulatory (11406)
Research institute (638)
Resumes & cover letters (60)
Southern California (740)
Startups (1697)
United States (7788)
Vaccines (204)
Weight loss (100)
Date
Today (81)
Last 7 days (362)
Last 30 days (1337)
Last 365 days (15346)
2025 (2615)
2024 (15498)
2023 (17151)
2022 (22366)
2021 (23155)
2020 (21527)
2019 (16580)
2018 (13010)
2017 (15297)
2016 (14281)
2015 (16845)
2014 (13267)
2013 (11189)
2012 (11989)
2011 (12492)
2010 (11404)
Location
Africa (325)
Asia (22033)
Australia (2952)
California (1967)
Canada (931)
China (226)
Colorado (91)
Connecticut (78)
Delaware (60)
Europe (43442)
Florida (305)
Illinois (199)
Indiana (125)
Japan (82)
Kansas (58)
Maryland (264)
Massachusetts (1556)
Minnesota (107)
New Jersey (753)
New York (588)
North Carolina (406)
Northern California (885)
Pennsylvania (469)
South America (510)
Southern California (740)
Texas (254)
Utah (57)
Virginia (64)
Washington State (126)
291,832 Results for "pivot pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Petros Pharmaceuticals’ Proprietary Technology Demonstrates Positive Data in Pivotal Study
February 26, 2025
·
7 min read
Press Releases
Completion of the Pivotal Phase 3 Trial for Olanzapine LAI in Schizophrenia Conducted by Teva Pharmaceuticals
February 10, 2025
·
1 min read
Press Releases
TAHO Pharmaceuticals Reports Positive Results from Pivotal Study of TAH3311, the First Oral Dissolving Film Anticoagulant
February 17, 2025
·
3 min read
Press Releases
TAHO Pharmaceuticals Completes Pivotal Trial of TAH3311, the First Oral Dissolving Film Anticoagulant
January 21, 2025
·
3 min read
Duchenne muscular dystrophy
Regenxbio Gears Up to Challenge Sarepta in DMD as Gene Therapy Advances to Pivotal Studies
Regenxbio is pushing its Duchenne muscular dystrophy gene therapy into pivotal development, with a BLA planned for 2026—potentially posing a threat to Sarepta’s Elevidys.
November 19, 2024
·
2 min read
·
Tristan Manalac
Pipeline
Kiniksa Axes Sjögren’s Program, AstraZeneca-Licensed Antibody in Cardio Pivot
Kiniksa will now focus its development efforts on the IL-1 blocker KPL-387, which it is testing for recurrent pericarditis with Phase II/III trials planned for mid-2025.
February 26, 2025
·
2 min read
·
Tristan Manalac
Podcast
Lilly’s Q3 Miss, Novo’s MASH Win, CAR T’s Autoimmune Pivot, More
In our anniversary episode, we discuss a rare earnings miss for Eli Lilly, a pivotal metabolic dysfunction–associated steatohepatitis victory for Novo Nordisk’s Wegovy, growing excitement about CAR Ts for autoimmune disease and the ongoing controversy over HeLa cells.
November 6, 2024
·
1 min read
·
Heather McKenzie
Press Releases
Anivive Announces Completion of LAVERDIA®-CA1 Pivotal Field Study for Canine Lymphoma
February 17, 2025
·
2 min read
Gene therapy
Pfizer Axes Beqvez Worldwide, Pivoting Away From Gene Therapy for Hemophilia
The move comes weeks after Pfizer terminated its partnership with Sangamo Therapeutics for another hemophilia gene therapy.
February 21, 2025
·
2 min read
·
Tristan Manalac
Press Releases
CereVasc Announces First Patient Randomized to eShunt® System Treatment in STRIDE Pivotal Trial
February 25, 2025
·
3 min read
1 of 29,184
Next
